KLKang-Yong Liu

Kang-Yong Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kang-Yong Liu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2009
      • Vol. 40  (1) , 67-71

    [Autophagy in the pathogenesis of Parkinson's disease].

    by Ji-Jun Shi, Kang-Yong Liu, Ya-Ping Yang


  • Stereotactic treatment of refractory obsessive compulsive disorder by bilateral capsulotomy with 3 years follow-up

    by Kangyong Liu, Haiyin Zhang, Chunfeng Liu, Yihui Guan, Liqin Lang, Yanbo Cheng, Bomin Sun, Hui Wang, Chuantao Zuo, Li Pan, et al.


    • 1 January 2008
      • Vol. 24  (1) , 23-6

    [Construction of eukaryotic expression vector containing hSNCA gene and its pathogenic mutants and its expression in PC12 cells].

    by Jin-Jun Qian, Yan-Bo Cheng, Chun-Feng Liu, Ya-Ping Yang, Kang-Yong Liu

    To construct recombinant eukaryotic expression vectors pEGFP-C3-SNCA containing human wild-type (WT) and pathogenic mutations A30P, A53T alpha-synuclein (SNCA), and to obtain monoclonal PC12 cell lines overexpressing human wild-type and pathogenic mutations A30P, A53T alpha-synuclein by stable transfection. Human wild type SNCA gene was cloned by using RT-PCR. By T-A extension cloning, the gene was ligated with T-vector and sequenced. Based on it, the recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its G88C (Ala30Pro) and G209A (Ala53Thr) pathogenic mutation were constructed by site-directed mutagensis using primer variance in mononucleotide. And different recombinant plasmids pEGFP-C3-SNCA were identified with PCR, restriction enzyme digestion and DNA sequencing. PC12 cells were transfected with different recombinant plasmids pEGFP-C3-SNCA by liposome transfection method, screened with G418, and subcloned by limited dilution method to obtain different monoclonal PC12 cell lines stably over-expressing human wild-type, A30P or A53T alpha-synuclein, respectively, and PC12 cells stably transfected with pEGFP-C3 were used as control group. These monoclonal PC12 cell lines were identified with RT-PCR, Western blot and fluorescence microscopy. According to result of PCR, the double digestion and gene sequencing, it was comfirmed that recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutation had been constructed successfully. By means of RT-PCR, Western blot and fluorescence microscope, it was comfirmed that objective gene sequences in PC12 cells were stably over-expressed. The recombinant pEGFP-C3-SNCA vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutations had been constructed successfully. The transfected monoclonal PC12 cells are obtained in which three SNCA gene isoforms had stable expression.